Brief: Ocugen Announces Compelling Preliminary Data For Ocu410—A

Ocugen

19/11/2024 12:16

Nov 19 (Reuters) - Ocugen Inc  OCGN.O :
    * OCUGEN ANNOUNCES COMPELLING PRELIMINARY DATA FOR OCU410—A
SINGLE
DOSE NOVEL MODIFIER GENE THERAPY TO TREAT GEOGRAPHIC ATROPHY
SECONDARY TO DRY AGE-RELATED MACULAR DEGENERATION

Source text:  ID:nGNX2nXyFb 
Further company coverage:  OCGN.O 

 ((Reuters.Briefs@thomsonreuters.com;))